CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Virtual reality exposuredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06446518
NCT06446518N/ACompleted

A Randomized Control Trial for Assessing Virtual Reality for Perioperative Anxiolysis and Postoperative Pain Modulation in Adolescents Undergoing MIRPE Surgery

Semmelweis University·interventional·Posted Jun 6, 2024·Updated Sep 8, 2025

In Brief

A clinical study evaluating Virtual reality exposure for Pectus Excavatum and Pectus Deformity. Completed, enrolled 50 participants across 1 site.

Detailed Summary

In this randomized control trial, investigators would like to assess as primary objective the effectiveness of VR in anxiolysis via using State Trait Anxiety- Inventory test various time during the perioperative period with recorded physiologic data. As a secondary objective they are investigating the use of VR in the postoperative period for pain modulation via using pain numeric rating scales (NRS), monitoring physiologic data, and collecting information on painkiller demand of the patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesHungary

Timeline

N/ACompletedFinished
2023202420252026
First PostedJun 6, 2024
Enrollment StartAug 17, 2022
Primary CompletionDec 10, 2024
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 2.1 years ago

Interventions

Virtual reality exposuredevice

Assessing immersive virtual reality as a distraction tool in anxiolysis and pain modulation.